References
- 1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 2011; 8:30–41.
- 2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007; 93:1137–1146.10.1136/hrt.2003.025270
- 3. Ramani GV, Uber PA, Mehra MR. Chronic Heart Failure: Contemporary Diagnosis and Management. Mayo. Clin. Proc. 2010; 85:180–195.
- 4. Moris D, Spartalis M, Spartalis E, Karachaliou GS, Karaolanis GI, Tsourouflis G, Tsilimigras DI, Tzatzaki E, Theocharis S. The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox. Ann Transl Med. 2017; 5(16): 326.
- 5. Choy PC, Siow YL, Mymin DOK. Lipids and atherosclerosis. Biochem. Cell. Biol. 2004; 82:212-24.10.1139/o03-085
- 6. Daniels TF, Killinger KM, Michal JJ, Wright RW Jr, Jiang Z. Lipoproteins, cholesterol homeostasis and cardiac health. Int J Biol Sci. 2009; 5(5): 474-88.10.7150/ijbs.5.474
- 7. Olatunji LA, Soladoye AO. Effect of increased magnesium intake on plasma cholesterol, triglyceride and oxidative stress in alloxan-diabetic rats. Afr. J. Med. Med. Sci. 2007; 36:155-61.
- 8. Xu CB, Sun Y, Edvinsson L. Cardiovascular risk factors regulate the expression of vascular endothelin receptors. Pharmacol. Ther. 2010; 127:148-55.
- 9. Kobayashi T, Miyauchi T, Sakai S, et al. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart. Am. J. Physiol. 1999; 276:H1197-206.
- 10. Liao JK, Laufs U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 005; 245:89–118.
- 11. Kavalipati N, Shah J, Ramakrishan A, Vasnawala H. Pleiotropic effects of statins Indian J Endocrinol Metab. 2015; 19(5): 554–562.
- 12. Haehling SV. Statins for heart failure: still caught in no man’s land? Clinical Science. 2009; 116:37–39.
- 13. Gotto AM. Statins, cardiovascular disease and drug safety. Am. J. Cardiol. 2006; 97:3-5.10.1016/j.amjcard.2005.12.005
- 14. Maghrani M, Zeggwagh N, Haloui M, Eddouks M. Acute diuretic effect of aqueous extract of Retamaraetam in normal rats. J. Ethnopharmacol. 2005; 99:31-35.
- 15. Lal AAS, Tkumar PBM. Pillai KS. Hypolipidemic effect of Coriandrum sativum L. intriton-induced hyperlipidemic rats. Indian J. Exp. Biol. 2004; 42:909–912.
- 16. Dhanapakiam P, Joseph JM, Ramaswamy VK. The cholesterol lowering property of coriander seeds (Coriandrum sativum): Mechanism of action. J. Environ. Biol. 2008; 29:53-56.
- 17. Samojlik I, Lakic N, Mimica-Dukic N, Dakovic-Svajcer K, Bozin B. Antioxidant and hepatoprotective potential of essential oils of coriander (Coriandrum sativum L.) and caraway (Carum carvi L.) (Apiaceae). J. Agric. Food Chem. 2010; 56:139-147.
- 18. Patel DK, Desai SN, Gandhi HP, Devkar RV, Ramachandran AV. Food and Chemical Toxicology. Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats. Food Chem. Toxicol. 2012; 50:3120–3125.10.1016/j.fct.2012.06.033
- 19. Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M. Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure rats. J. Cardiovasc. Pharmacol. Ther. 2012; 17:199-207.
- 20. Jollow DJ, Mitchell JR, Zampaglione N, Gillete JR. Bromobenzene induced liver necrosis: protective role of Glutathione and evidence for 3-4,bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 1974; 11:151-159.10.1159/000136485
- 21. Mohandas M, Marshall JJ, Duggin GG, Horvath JS, Tiller D. Differential Distribution Of Glutathione And Glutathione Related Enzymes In Rabbit Kidney. Cancer Research 1984; 44:5086–5091.
- 22. Carlberg L, Mannervick B. Glutathione reductase level in rat brain. Journal of biological chemistry 1975; 250: 5575-5580.
- 23. Clairborne A. Catalase activity, CRC Press, Handbook of Methods for Oxygen Radical Research; R. Greenwald, 1985; Ed: 283–284.
- 24. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47:469–474.10.1111/j.1432-1033.1974.tb03714.x
- 25. Wright JR, Colby HD, Miles PR. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophys. 1981; 206:296–304.
- 26. Ikewuchi JC, Ikewuchi CC. Alteration of plasma lipid profile and atherogenic indices of cholesterol loaded rats by Tridax procumbensm Linn: Implications for the management of obesity and cardiovascular diseases. Biokemistri. 2009; 21:95-9.
- 27. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29:2003-2007.
- 28. Khalil MI, Ahmmed I, Ahmed R, Tanvir EM, Afroz R, Paul S, Gan SH, Alam N. Amelioration of Isoproterenol-Induced Oxidative Damage in Rat Myocardium by Withania somnifera Leaf Extract. Biomed Res Int. 2015; 2015: 624159.
- 29. Sharma M, Kishore K, Gupta SK, Joshi S, Arya DS. Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 2001; 225: 75-83.
- 30. Yeager JC, Iams SG. The hemodynamics of isoproterenol-induced cardiac failure in the rat. Circ. Shock. 1981; 8:151-63.
- 31. Dickinson MG, John H, Olshansky B, et al. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators. Am. Heart. J. 2007; 153:573-578.
- 32. Melo EA, Bion FM, Filho JM, Guerra NB. In vivo antioxidant effect of aqueous and etheric coriander (Coriandrum sativum L.) extracts. Eur. J. Lipid Sci. Technol. 2003; 105:483-487.
- 33. Rajeshwari U, Andallu B. Medicinal benefits of coriander (Coriandrum Sativum L). Spatula DD. 2011; 1:51-58.
- 34. Kay CD, Hooper L, Kroon PA, Rimm EB, Cassidy A. Relative impact of flavonoid composition, dose and structure on vascular function: A systematic review of randomized controlled trials of flavonoid-rich food products. Mol. Nutr. Food Res. 2012; 256:1605-16.
- 35. Yang L, Jia Z, Yang L, et al. Exercise Protects against Chronic β-Adrenergic Remodeling of the Heart by Activation of Endothelial Nitric Oxide Synthase. PLoS One. 2014; 9:e96892.
- 36. Simko F, Bednarova KR, Krajcirovicova K, et al. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. J. Pineal Res. 2014; 57:177-84.10.1111/jpi.12154
- 37. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am. J. Physiol. Heart Circ. Physiol. 2011; 301:H2181-90.
- 38. Gaweł S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad. Lek. 2004; 57:453-5.
- 39. Rajadurai M, Prince PSM. Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats. J. Biochem. Mol. Toxicol. 2006; 20:191-197.10.1002/jbt.20136
- 40. Murugesan M, Revathi R, Manju V. Cardioprotective effect of fenugreek on isoproterenol induced myocardial infarction in rats. Indian J Pharmacol. 2011; 43(5): 516–519.10.4103/0253-7613.84957
- 41. Tang ELH, Rajarajeswaran J, Fung SY, Kanthimathi MS. Antioxidant activity of Coriandrum sativum and protection against DNA damage and cancer cell migration. BMC Complementary and Alternative Medicine. 2013; 13:347.
- 42. Giardano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 2005; 115:500-508.
- 43. Morimoto C, Kiyama A, Kameda K, Ninomiya H, Tsujita T, Okuda H. Mechanism of the stimulatory action of okadaic acid on lipolysis in rat fat cells. The Journal of Lipid Research. 2000; 41(2): 199–20.
- 44. Radhiga T, Rajamanickam C, Senthil S, Pugalendi KV. Effect of ursolic acid on cardiac marker enzymes, lipid profile and macroscopic enzyme mapping assay in isoproterenol-induced myocardial ischemic rats. Food Chem Toxicol. 2012; 50(11): 3971-7.10.1016/j.fct.2012.07.067
- 45. Dhanapakiam P, Joseph JM, Ramaswamy VK, Moorthi M, Kumar AS. The cholesterol lowering property of coriander seeds (Coriandrum sativum): mechanism of action. J Environ Biol. 2008; 29(1): 53-6.
- 46. Bafna A, Maheshwari RS, Ved RK, Sarkar PD, Batham AR. Study of atherogenic indices in nephrotic syndrome. Int. J. Biol. Med. Res. 2012; 3:2257-2260.
- 47. Ohkita M, Tawa M, Kitada K, Matsumura Y. Pathophysiological Roles of Endothelin Receptors in Cardiovascular Diseases. J. Pharmacol. Sci. 2012; 119:302 – 313.
- 48. Stenman E, Malmsjo M, Uddman E, Gido G, Wieloch T, Edvinsson L. Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke. 2002; 33:2311-2316.10.1161/01.STR.0000028183.04277.32
- 49. Zheng JP, Zhang Y, Edvinsson L, Hjalt T, Xu CB. NFkappaB signaling mediates vascular smooth muscle endothelin type B receptor expression in resistance arteries. Eur. J. Pharmacol. 2010; 637:148−154.
- 50. Dimitrijevic I, Edvinsson ML, Chen Q, Malmsjo M, Kimblad PO, Edvinsson L. Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease. BMC Cardiovasc. Disord. 2009; 9:40.